IRIS Accounts Production v26.1.10.61 07998080 Board of Directors 1.6.24 31.5.25 31.5.25 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh079980802024-05-31079980802025-05-31079980802024-06-012025-05-31079980802023-05-31079980802023-06-012024-05-31079980802024-05-3107998080ns15:EnglandWales2024-06-012025-05-3107998080ns14:PoundSterling2024-06-012025-05-3107998080ns10:Director12024-06-012025-05-3107998080ns10:PrivateLimitedCompanyLtd2024-06-012025-05-3107998080ns10:SmallEntities2024-06-012025-05-3107998080ns10:AuditExempt-NoAccountantsReport2024-06-012025-05-3107998080ns10:SmallCompaniesRegimeForDirectorsReport2024-06-012025-05-3107998080ns10:SmallCompaniesRegimeForAccounts2024-06-012025-05-3107998080ns10:FullAccounts2024-06-012025-05-310799808012024-06-012025-05-3107998080ns10:Director42024-06-012025-05-3107998080ns10:Director52024-06-012025-05-3107998080ns10:Director62024-06-012025-05-3107998080ns10:CompanySecretary12024-06-012025-05-3107998080ns5:CurrentFinancialInstruments2025-05-3107998080ns5:CurrentFinancialInstruments2024-05-3107998080ns5:Non-currentFinancialInstruments2025-05-3107998080ns5:Non-currentFinancialInstruments2024-05-3107998080ns5:ShareCapital2025-05-3107998080ns5:ShareCapital2024-05-3107998080ns5:RetainedEarningsAccumulatedLosses2025-05-3107998080ns5:RetainedEarningsAccumulatedLosses2024-05-3107998080ns5:NetGoodwill2024-06-012025-05-3107998080ns5:IntangibleAssetsOtherThanGoodwill2024-06-012025-05-3107998080ns5:NetGoodwill2024-05-3107998080ns5:NetGoodwill2025-05-3107998080ns5:NetGoodwill2024-05-3107998080ns5:PlantMachinery2024-05-3107998080ns5:PlantMachinery2024-06-012025-05-3107998080ns5:PlantMachinery2025-05-3107998080ns5:PlantMachinery2024-05-3107998080ns5:CostValuation2024-05-3107998080ns5:WithinOneYearns5:CurrentFinancialInstruments2025-05-3107998080ns5:WithinOneYearns5:CurrentFinancialInstruments2024-05-31
REGISTERED NUMBER: 07998080 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MAY 2025

FOR

PHARMASIA8 LIMITED

PHARMASIA8 LIMITED (REGISTERED NUMBER: 07998080)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2025










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


PHARMASIA8 LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MAY 2025







DIRECTORS: Mr N M Shah
K Shah
A M Shah
A Shah





SECRETARY:





REGISTERED OFFICE:





REGISTERED NUMBER: 07998080 (England and Wales)





ACCOUNTANTS: Ashfords Partnership LLP
114 - 116 Goodmayes Road
Ilford
Essex
IG3 9UZ

PHARMASIA8 LIMITED (REGISTERED NUMBER: 07998080)

BALANCE SHEET
31 MAY 2025

31.5.25 31.5.24
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 648,916 648,916
Tangible assets 5 1,112 1,482
Investments 6 100 100
650,128 650,498

CURRENT ASSETS
Stocks 79,323 27,618
Debtors 7 219,908 261,550
Cash at bank and in hand 127,342 1,653,889
426,573 1,943,057
CREDITORS
Amounts falling due within one year 8 570,639 773,861
NET CURRENT (LIABILITIES)/ASSETS (144,066 ) 1,169,196
TOTAL ASSETS LESS CURRENT
LIABILITIES

506,062

1,819,694

CREDITORS
Amounts falling due after more than one
year

9

89,829

100
NET ASSETS 416,233 1,819,594

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 416,133 1,819,494
SHAREHOLDERS' FUNDS 416,233 1,819,594

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 May 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 May 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

PHARMASIA8 LIMITED (REGISTERED NUMBER: 07998080)

BALANCE SHEET - continued
31 MAY 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 25 May 2026 and were signed on its behalf by:





A Shah - Director


PHARMASIA8 LIMITED (REGISTERED NUMBER: 07998080)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2025


1. STATUTORY INFORMATION

Pharmasia8 Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 0, is being amortised evenly over its estimated useful life of nil years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

PHARMASIA8 LIMITED (REGISTERED NUMBER: 07998080)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MAY 2025


3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 6 (2024 - 6 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 June 2024
and 31 May 2025 648,916
NET BOOK VALUE
At 31 May 2025 648,916
At 31 May 2024 648,916

5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 June 2024
and 31 May 2025 87,722
DEPRECIATION
At 1 June 2024 86,240
Charge for year 370
At 31 May 2025 86,610
NET BOOK VALUE
At 31 May 2025 1,112
At 31 May 2024 1,482

6. FIXED ASSET INVESTMENTS
Other
investments
£   
COST
At 1 June 2024
and 31 May 2025 100
NET BOOK VALUE
At 31 May 2025 100
At 31 May 2024 100

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.5.25 31.5.24
£    £   
Trade debtors 139,747 182,654
Other debtors 80,161 78,896
219,908 261,550

PHARMASIA8 LIMITED (REGISTERED NUMBER: 07998080)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MAY 2025


8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.5.25 31.5.24
£    £   
Trade creditors 297,613 156,678
Taxation and social security 214,153 171,831
Other creditors 58,873 445,352
570,639 773,861

9. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
31.5.25 31.5.24
£    £   
Amounts owed to group undertakings 89,829 -
Other creditors - 100
89,829 100

Amounts falling due in more than five years:

Repayable by instalments
Debentures more 5yrs-instalm - 100